The current study focused on the effects of chrysophanol on cell motility and cancer metabolism in CRC via the KITENIN and ErbB4 pathways, and the results provide a new perspective on the previously demonstrated anticancer effects of chrysophanol. The gene discussed is VANGL1; the disease is colorectal carcinoma.